Allarity (ALLR) Therapeutics, a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib, a differentiated, dual PARP and WNT pathway inhibitor, announced that Dr Jeremy Graff, ...

Paul Shawah, EVP, strategy, Veeva Systems and Richard Staub, president, R&D solutions, IQVIA, explain how their partnership is improving efficiency and data management in clinical trials by ...

TORONTO — Some doctors and bioethicists are raising concerns about a Toronto hospital's partnership with a company founded by U.S. billionaire Elon Musk. University Health Network announced earlier ...

First-ever clinical data supporting safety and efficacy of in vivo CAR-T Therapy in refractory systemic lupus erythematosus (SLE) patients. Data shows low dose of HN2301 reprogrammed up to 60% of CD8 ...

1 Department of Cardiology, The Third People’s Hospital of Yunnan, Kunming, Yunnan, China 2 Department of SICU, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular ...

CARY, N.C., Sept. 15, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the launch of WCG ClinSphere™ eReview ...

Paul Hingst, Prasun Mishra, and Naymisha Patel discussed risk management in clinical trials as a key measure to ensure supply and trial success. Credit: Athanasios Psimadis/ Arena International Events ...

Cognitive outcomes observed in the oral blarcamesine 30 mg Precision Medicine cohort move toward normal aging profiles across validated clinical scales, supporting its relevance in early-stage ...

Oversubscribed £50m Series B led by SV Health Investors’ Dementia Discovery Fund, alongside other new investors British Business Bank, M Ventures, Novartis Venture Fund and Criteria Bio Ventures, ...